Mangoceuticals (MGRX) Receivables - Other (2025 - 2026)

Mangoceuticals' (MGRX) quarterly Receivables - Other came in at $20056.0 in Q1 2026, little changed quarter-over-quarter from $20056.0 in Q4 2025.

Mangoceuticals (MGRX) Receivables - Other (2025 - 2026) Analysis & Trends

Mangoceuticals has disclosed Receivables - Other across 2 years of filings, most recently posting $20056.0 for Q1 2026.

Receivables - Other for Q1 2026 came in at $20056.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $20056.0 (changed N/A YoY), and the FY2025 annual result was $20056.0, changed N/A from the prior year.
Receivables - Other came in at $20056.0 for Q1 2026 at Mangoceuticals, roughly flat from $20056.0 in the prior quarter.
In the past five years, Receivables - Other ranged from a high of $20056.0 in Q4 2025 to a low of $20056.0 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Veeva Systems	26.11 Bn	18.79 Bn	662.02 Mn
2	BrightSpring Health Services	12.95 Bn	12.07 Bn	482.22 Mn
3	Healthequity	7.46 Bn	7.19 Bn	256.31 Mn
4	Hinge Health	5.15 Bn	4.83 Bn	154.23 Mn
5	Doximity	3.75 Bn	3.00 Bn	125.97 Mn
6	10x Genomics	3.69 Bn	3.15 Bn	106.18 Mn
7	Waystar Holding	3.61 Bn	3.45 Bn	268.04 Mn
8	Privia Health	2.90 Bn	2.54 Bn	595.71 Mn
9	Omnicell	1.72 Bn	1.54 Bn	140.36 Mn
10	Mangoceuticals	6.01 Mn	5.82 Mn	29,001.00

Download Data